ID
34057
Descrizione
Study ID: 101998 Clinical Study ID: 101998 Study Title: A randomized, double-blind, parallel group, placebo-controlled, single-attack evaluation of the efficacy and tolerability of TREXIMA™ (sumatriptan 85mg/naproxen sodium 500mg)* tablets vs placebo when administered during the mild pain phase of a migraine Patient Level Data Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier Sponsor GlaxoSmithKline Collaborators N/A Phase Phase 3 Study Recruitment Status Completed Generic Name sumatriptan Trade Name Imitrex ,Imiject ,Imigran Study Indication Migraine Disorders This document asks if the subject is of child-bearing potential and which birth control methods the subject is using to prevent pregnancy during the study. This form should be filled out by female subjects at the screening visit.
Keywords
versioni (3)
- 2019-01-11 2019-01-11 -
- 2019-01-13 2019-01-13 -
- 2019-01-17 2019-01-17 -
Titolare del copyright
GlaxoSmithKline
Caricato su
13 januari 2019
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY-NC 3.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
Efficacy and Tolerability of TREXIMA Tablets vs. Placebo During Mild Migraine Study ID 101998
Child Bearing Potential and Birth Control
- StudyEvent: ODM
Similar models
Child Bearing Potential and Birth Control
- StudyEvent: ODM
C0086129 (UMLS CUI [1,2])
C0004764 (UMLS CUI [1,2])
C0042241 (UMLS CUI [2])
C3873750 (UMLS CUI [3])
C2348235 (UMLS CUI [1,2])